Toll free

18002022232

Blogs

Tarlatamab for lung cancer – innovative targeted therapy attacking cancer cells

Tarlatamab: A New Drug Shows Promise

Lung cancer is one of the deadliest cancers in the world, and small-cell lung cancer

24 July 2025

Read more
Targeted cancer cell therapy illustration highlighting SunAct’s advanced cancer cellular therapies in India

How SunAct Offers Advanced Cancer Cellular Therapies Across India

Cancer remains one of the most pressing global health challenges…

05 July 2025

Read more
Visual representation of Talquetamab antibody bridging to BCMA CAR-T therapy in relapsed/refractory multiple myeloma treatment.

Talquetamab as a Bridge: Closing the Gap to BCMA CAR T

BCMA-targeted CAR T cell therapies like idecabtagene ….

20 June 2025

Read more
Immune cells activated for T-cell therapy showing personalized CAR T-cell treatment to fight cancer

Fighting Cancer with your own Supercharged Cells

Imagine if we could take a person’s own T-cells (a type of immune cells), train them…

20 June 2025

Read more
Illustration of immune system treating AL amyloidosis using patient’s own plasma cells in immunotherapy

A Breakthrough for AL Amyloidosis: Using Your Own Immune System

Imagine a factory in your body (your plasma cells) that is supposed to make….

20 June 2025

Read more
Visualization of dual-target CAR T-cell therapy for mantle cell lymphoma treatment using modified T-cells

Double-Target CAR-T: A Promising New Treatment

Mantle cell lymphoma (MCL) is a type of blood cancer that affects B-cells, …

20 June 2025

Read more
Depiction of off-the-shelf “ready-made” CAR T therapy used for large B-cell lymphoma (LBCL) treatment

“Ready-Made” Cell Therapy: A New Hope for Lymphoma Treatment?

Large B-cell lymphoma (LBCL) is a fast-growing cancer of the…

20 June 2025

Read more
Immune cell attacking platelets in autoimmune thrombocytopenia (ITP), with concept of immune system reset therapy

A Fresh Start for the Immune System

Immune Thrombocytopenia (ITP) is an autoimmune condition where the body’s immune system mistakenly attacks its own platelets, the tiny cells essential for blood clotting.

20 June 2025

Read more
Gamma delta T-cells attacking cancer cells visual representation of SunAct’s advanced immunotherapy for hard-to-treat cancers

SunAct’s Gamma Delta T-cell therapy - A game changer for the Cancer

Cancer is one of the leading causes of death worldwide. While treatments….

18 June 2025

Read more
Glioblastoma brain tumor illustration showing targeted CAR T-cell treatment breakthroughs for brain cancer

New Hope for Brain Cancer: A Breakthrough

Glioblastoma is one of the most dangerous brain cancers out there…

10 June 2025

Read more
Immune cells attacking rhabdomyosarcoma cells concept image for childhood cancer treatment innovations

A New Horizon in Childhood Cancer Treatment

Rhabdomyosarcoma, a rare and aggressive cancer primarily affecting children and…

07 June 2025

Read more
Modified CAR T-cells targeting autoimmune platelets in immune thrombocytopenia (ITP) concept of immune reset therapy

Reprogramming Immunity: Can CAR-T Cells Conquer Refractory ITP?

Immune thrombocytopenia (ITP) is an autoimmune disorder marked ….

03 June 2025

Read more
Illustration of ready-made CAR T-cells targeting lymphoma B-cells innovative immunotherapy for LBCL treatment

“Off-the-Shelf” CAR-T: A New Dawn for Lymphoma Treatment?

Large B-cell lymphoma (LBCL) is an aggressive malignancy of mature B cells….

03 June 2025

Read more
High-tech concept of engineered CAR-T cells designed for precision immunotherapy targeting cancer mutations

Immunity, Evolved: CAR-T the Rise of Precision Immune Engineering

The immune system has always been our body’s…

10 April 2025

Read more
Child resting in hospital bed SunAct’s timely pediatric HSCT (stem cell transplant) for improved leukemia outcomes

Timely Referral for Pediatric HSCT: A Key to Better Outcomes

For children with certain life-threatening conditions like leukaemia…

11 April 2025

Read more
Doctor analyzing brain scan - SunAct's CAR-T therapy offering hope for aggressive glioblastoma treatment

CAR-T Cell Therapy for
Glioblastoma

Glioblastoma is the most common and aggressive primary malignant brain tumor…

03 March 2025

Read more
Young patient with pediatric nurse at SunAct's CAR T-cell therapy transforming pediatric oncology care

CAR T-Cell Therapy in Pediatric Oncology

Chimeric Antigen Receptor (CAR) T-cell therapy has revolutionized pediatric oncology…

02 January 2025

Read more

Is Cancer in Your Genes? Understanding Hereditary Risks

The other day, while I was sitting in my OPD, a worried couple came to see me…

15 December 2024

Read more
Doctor explaining cancer to elderly patient at SunAct provides patient education and clarity on cancer basics

What exactly is cancer? A simple guide

The word itself can stir up fear and uncertainty, but understanding it can help remove ….

01 December 2024

Read more
Instagram Youtube Linkedin Facebook
Quick Links
Therapies
Reach Us
Our Centres

Mumbai (Thane, Khar) | Kerala (Thodupuzha) | Nashik

Email Support

[email protected]

Let's Talk

Phone: +91 86553 13412
Toll Free: 1800 202 2232

Copyright© 2025 SunAct. All rights reserved. Powered by Regisdigitals.
Disclaimer: The information on this website is for general knowledge purposes only and does not constitute medical advice, diagnosis, or treatment in any form. It is not a substitute for professional medical advice from a qualified physician. Additionally, you are browsing the official and only website of SunAct and not an agent or affiliate website.

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

proceed to call

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct head and neck cancer case study using TCR-p53 therapy in inoperable squamous cell carcinoma
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male